A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH

NCT03062280 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Adrenal Hyperplasia

Interventions

DRUG: Hydrocortisone

Sponsor

Neurocrine UK Limited